The global extracorporeal membrane oxygenation machine market size is anticipated to reach to reach USD 445.7 million by 2030, expanding at a CAGR of 5.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of cardiopulmonary and respiratory diseases, increasing adoption of ECMO machines in hospitals, and technological advancements in ECMO machines. The market expansion is also driven by the need for advanced life support technologies like ECMO machines, which are becoming increasingly necessary in treating patients with severe or life-threatening cardiac or pulmonary conditions.
Extracorporeal Membrane Oxygenation Machine Market Report Highlights
- In 2023, the oxygenators segment accounted for the largest market share. This can be attributed due to prevalence of diseases like coronary heart disease and chronic obstructive pulmonary disease (COPD) continues to rise, the demand for advanced life support technologies like ECMO machines increases, driving the growth of the oxygenators segment.
- The veno-arterial segment dominated the modality segment of ECMO machine market in 2023. This growth can be attributed due to high usage of veno-arterial ECMO in treating patients with cardiac arrest, where it assists with algorithm life support strategies to restore blood circulation. Additionally, the increasing incidence of chronic obstructive pulmonary disease (COPD) is also a key driver of this market segment.
- The respiratory segment dominated the application segment in 2023 due to the high prevalence of respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and acute respiratory distress syndrome (ARDS), which are leading causes of death worldwide, necessitate advanced life support technologies like ECMO machines.
- The adult patient segment dominated the patient type segment in 2023 due to the prevalent incidence of heart and lung-related issues necessitating life-saving interventions.
- The North American region held the largest share of the market in 2023 due to key industry players, consistent product launches, government backing for quality healthcare, advanced healthcare infrastructure, and favorable reimbursement policies.
- Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
For More Details or Sample Copy please visit link @: Extracorporeal Membrane Oxygenation Machine Market Report
The rising prevalence of cardiovascular and respiratory diseases. Diseases such as coronary heart disease, cerebrovascular disease, rheumatic and congenital heart diseases, respiratory diseases like acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary diseases are leading causes of death worldwide. For instance, according to the World Heart Federation, approximately 18.6 million people die annually from cardiovascular diseases. Additionally, about 190,000 Americans are diagnosed with ARDS annually in the U.S. Such an increasing prevalence of cardiovascular and respiratory diseases has boosted the demand for ECMO machines, driving the market growth.
In addition, the increasing rate of technical improvement is increasing the usage of products. It is easier to transfer critically ill patients now as machine parts like hollow pumps and oxygenators are smaller. Moreover, introducing technologically advanced components, such as improved rotary pumps, dual-lumen cannulas, innovative oxygenators, and new cannulation approaches, is anticipated to ease the use of ECMO machines. For instance, in 2022, Inspira Technologies OXY B.H.N. Ltd. recently introduced the “Liby” System, an advanced life support system used to treat patients with life-threatening heart and lung failure. Similar advancements and the introduction of new products are expected to drive market growth in the coming years.
List of top Players of Extracorporeal Membrane Oxygenation Machine Market
- Medtronic Plc
- Maquet Holding
- Microport Scientific Corporation
- Terumo Cardiovascular System Corporation
- Medos Medizintechnik
- Nipro Medical Corporation
- LivaNova PLC
- CytoSorbents Corporation
- EUROSETS S.R.L
Gain deeper insights on the market and receive your free copy with TOC now @: Extracorporeal Membrane Oxygenation Machine Market Growth Report
We have segmented the global extracorporeal membrane oxygenation machine market on the basis of component, modality, application, patient type and region.
Extracorporeal Membrane Oxygenation (ECMO) Machine Component Outlook
- Pumps
- Oxygenator
- Controllers
- Cannula
- Accessories
Extracorporeal Membrane Oxygenation (ECMO) Machine Modality Outlook
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
Extracorporeal Membrane Oxygenation (ECMO) Machine Patient Type Outlook
- Neonates
- Pediatric
- Adult
Extracorporeal Membrane Oxygenation (ECMO) Machine Application Outlook
- Respiratory
- Cardiac
- ECPR
Extracorporeal Membrane Oxygenation (ECMO) Machine Region Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Explore Horizon, the world’s most expansive market research database
#ECMO #ExtracorporealMembraneOxygenation #MedicalDevices #HealthcareTechnology #CardiovascularCare #CriticalCare #NeonatalCare #RespiratorySupport #MedicalEquipment #HealthTech #LifeSupportSystems #MarketAnalysis #HealthcareMarket #MedicalInnovation #PatientCare #IntensiveCare #ECMOMachine #Cardiology #MedicalResearch #HealthcareIndustry
